SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-092163
Filing Date
2024-08-07
Accepted
2024-08-06 19:48:56
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-20240630.htm   iXBRL 10-Q 1872743
2 EX-10.9 acad-ex10_9.htm EX-10.9 37659
3 EX-31.1 acad-ex31_1.htm EX-31.1 10657
4 EX-31.2 acad-ex31_2.htm EX-31.2 10807
5 EX-32.1 acad-ex32_1.htm EX-32.1 7526
6 EX-32.2 acad-ex32_2.htm EX-32.2 7584
  Complete submission text file 0000950170-24-092163.txt   7705381

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20240630.xsd EX-101.SCH 920575
66 EXTRACTED XBRL INSTANCE DOCUMENT acad-20240630_htm.xml XML 1464819
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 241180997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)